Implications of Pathologic Complete Response Beyond Mediastinal Nodal Clearance With High-Dose Neoadjuvant Chemoradiation Therapy in Locally Advanced, Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Implications of Pathologic Complete Response Beyond Mediastinal Nodal Clearance With High-Dose Neoadjuvant Chemoradiation Therapy in Locally Advanced, Non-Small Cell Lung Cancer

Published:2018-06 Issue:2 Volume:101 Page:445-452
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Vyfhuis Melissa A.L.,Burrows Whitney M.,Bhooshan Neha,Suntharalingam Mohan,Donahue James M.,Feliciano Josephine,Badiyan Shahed,Nichols Elizabeth M.,Edelman Martin J.,Carr Shamus R.,Friedberg Joseph,Henry Gavin,Stewart Shelby,Sachdeva Ashutosh,Pickering Edward M.,Simone Charles B.,Feigenberg Steven J.,Mohindra Pranshu

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference25 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. The IASLC lung cancer staging project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer;Goldstraw;J Thorac Oncol,2016

3. Non-small cell lung cancer, version 5.2017, NCCN Clinical Practice Guidelines in Oncology;Ettinger;J Natl Compr Canc Netw,2017

4. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage 3 NSCLC RTOG 0617;Bradley;Lancet Oncol,2015

5. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer;Antonia;N Engl J Med,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC;BMC Cancer;2023-12-21

2. Prospective Feasibility and Phase 1/2 Trial of Preoperative Proton Beam Therapy With Concurrent Chemotherapy for Resectable Stage IIIA or Superior Sulcus Non-Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2023-11

3. Association between event-free survival and overall survival after neoadjuvant treatment for non-small cell lung cancer: a systematic review and meta-analysis;Expert Review of Anticancer Therapy;2023-10-25

4. Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC;2023-09-26

5. Predictive factors of pathological complete response after induction (ypT0N0M0) in non-small cell lung cancer and short-term outcomes: Results of the Spanish Group of Video-assisted Thoracic Surgery (GE-VATS);Cirugía Española (English Edition);2022-06